| Term 
 
        | What is an NHP for treatment of chronic or terminal illness? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Problems associated with  Herbals  |  | Definition 
 
        | • Lack information on active ingredients. • Lack safety and efficacy data. • Lack of quality control-- Changing • Undeclared ingredients– Changing ?? • Intentional adulteration - • Source unknown and questionable. • Confusing literature. • Toxicities  some innocuous others not. • Drug interactions with allopathic drugs. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sedative and hypnotic – Contains valepotriates--  shown to have CNS  depressant activity with less adverse effect than  diazepam |  | 
        |  | 
        
        | Term 
 
        | Valerian's effect on sleep |  | Definition 
 
        | no difference may be useful in mild insomnia |  | 
        |  | 
        
        | Term 
 
        | Is Valerian more effective in cancer patients or postmenopausal women? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | An antibiotic and immune stimulant |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why is the efficacy of Echinacein questionable? |  | Definition 
 
        | It alters immune  cells but does it alter the outcome of the  cold |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heterogeneity of preparations – Need standardized preps –bioassay? • Some evidence that the aerial parts of  E.purpurea may have some effect. • Methodologies of trials vary. • Bias towards positive results- negative  results not published. |  | 
        |  | 
        
        | Term 
 
        | What does St. John's Wort contain? |  | Definition 
 
        | Contains hypericin  – High concentrations inhibit uptake of  serotonin and norepinephrine and dopamine  in CNS – As do other antidepressants. – Clinical trials – 55% versus placebo – Toxicities as with other antidepressants.  |  | 
        |  | 
        
        | Term 
 
        | Treatment of Minor depression with St john’s wort or Citalopram:  (2011) |  | Definition 
 
        | St.John’s Wort not different from placebo – Citalopram not different from placebo. |  | 
        |  | 
        
        | Term 
 
        | St. John’s Wort extract LI160 for the treatment of depression. mild depression |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | St. John’s Wort extract LI160 for the treatment of depression. HAM-D17 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | St. John’s Wort extract LI160 for the treatment of depression. CGI-S |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Contains Kava Lactones  -- anti-anxiety • Uses – Anxiolytics – supported by clinical trials  – Mild sedative |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Potentiates other CNS drugs –alcohol – Scaly skin condition – Not for pregnant women – Several warnings from Health Canada. Do not use. |  | 
        |  | 
        
        | Term 
 
        | Drug interactions with herbals |  | Definition 
 
        | Becoming a problem • Additive response  St john’s Wort and  antidepressants • Valerian and alcohol • Warfarin with ginseng and echinacea |  | 
        |  |